Skip to main content

Discussion on LYNPARZA


6:00 pm - 7:00 pm

Virtual Expert Discussion on LYNPARZA® (olaparib) 

Treatment of mCRPC with LYNPARZA:
An oral therapy for patients with HRR gene mutations following progression on enzalutamide or abiraterone


Presented by
Jacek Pinski, MD, PhD
Associate Professor of Medicine, Division of Medical
USC/Norris Comprehensive Cancer Center
Los Angeles, California


To register or for more information, contact
Lynn Harris at 626-622-2658 or